miR-4260 serves as a prognostic biomarker and suppresses thyroid cancer progression
Key Points
To investigate the role of miR-4260 in thyroid cancer progression and its potential as a biomarker.
Analysis of miR-4260 expression in thyroid cancer samples.
Evaluation of patient outcomes associated with miR-4260 levels.
Assessment of miR-4260's impact on cancer progression in vitro.
Higher levels of miR-4260 correlate with unfavorable patient outcomes.
miR-4260 suppresses thyroid cancer cell growth.
miR-4260 shows potential as a therapeutic target in thyroid cancer.
Abstract
miR-4260 is critically implicated in TC advancement and unfavorable patient outcomes, establishing its bifunctional value as a clinically significant prognostic indicator and viable therapeutic candidate.